Omkar Speciality Chemicals Ltd - Stock Valuation and Financial Performance

BSE: 533317 | NSE: OMKARCHEM | Chemicals | Small Cap

Omkar SpecialityChem Share Price

6.50 -0.28 -4.13%
as on 18-May'24 12:50

DeciZen - make an informed investing decision on Omkar SpecialityChem

M-Cap below 100cr DeciZen not available

Omkar Speciality Chemicals stock performance -

mw4me loader
P/E Ratio (SA):
Market Cap:
13.4 Cr.
52-wk low:
52-wk high:

Is Omkar Speciality Chemicals Ltd an attractive stock to invest in?

1. Is Omkar Speciality Chemicals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Omkar Speciality Chemicals Ltd is a below average quality company.

2. Is Omkar Speciality Chemicals Ltd undervalued or overvalued?

The key valuation ratios of Omkar Speciality Chemicals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Omkar Speciality Chemicals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Omkar Speciality Chemicals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Omkar SpecialityChem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Omkar Speciality Chemicals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 13.8%11.9%8.6%8.4%9.9%7.3%-35.3%-15.3%-14.4%4.4%-
Value Creation

Growth Parameters

Growth Parameters Colour Code Guide

Sales 16720221019330031719242.756.945.119
Sales YoY Gr.-20.7%4%-7.8%55.2%5.6%-39.5%-77.7%33.4%-20.7%-
Adj EPS 8.410.37.68.911.42.2-33.4-12-7-0.4-6.4
YoY Gr.-23.2%-26.6%17.7%27.1%-80.6%-1617.3%NANANA-
BVPS (₹) 53.962.868.579.288.2-1.4-60.8-72-79-76.90
Adj Net
Cash Flow from Ops. -
Debt/CF from Ops. -215.8960.56.43.3-13.21.79166.558.1-13.9-


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -13.5%-31.5%-38.3%-20.7%
Adj EPS -171.5%-151.5%NANA
Share Price -25.2% -12% -13.1% -11.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on
Equity %
Op. Profit
Mgn %
Net Profit
Mgn %
Debt to
Working Cap
Cash Conv.

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 16.70%

Sales growth has been subdued in last 3 years -38.25%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at -56.47%

Latest Financials - Omkar Speciality Chemicals Ltd.

Standalone Consolidated
TTM EPS (₹) -6.4 18
TTM Sales (₹ Cr.) 19.4 481
BVPS (₹.) 0 0
Reserves (₹ Cr.) -194 208
P/BV 0.00 0.00
PE 0.00 0.36
From the Market
52 Week Low / High (₹) 5.75 / 12.35
All Time Low / High (₹) 2.27 / 249.10
Market Cap (₹ Cr.) 13.4
Equity (₹ Cr.) 20.6
Face Value (₹) 10
Industry PE 51

Management X-Ray of Omkar SpecialityChem:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *76.9476.9476.9476.9476.9476.9463.8963.8956.7356.73
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Omkar SpecialityChem

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
Operating Expenses 133.75165.20176.72164.37254.61259.43234.9544.5357.1237.75
Manufacturing Costs8.4114.0611.6511.828.527.9311.086.235.476.41
Material Costs114.34136.36147.17134.28227.59236.40210.4228.4044.4326.83
Employee Cost 5.506.929.888.338.237.753.033.492.781.96
Other Costs 5.507.868.039.9510.287.3410.436.424.442.56
Operating Profit 33.1936.3332.9028.9445.4157.31-43.36-1.88-0.247.37
Operating Profit Margin (%) 19.9%18.0%15.7%15.0%15.1%18.1%-22.6%-4.4%-0.4%16.3%
Other Income 3.705.795.754.918.752.253.693.040.450.86
Interest 8.107.4311.7511.4316.5221.8326.1314.624.935.57
Depreciation 5.625.686.101.974.2810.908.167.996.593.56
Exceptional Items 00-0.0700-163.62-52.599.9304.04
Profit Before Tax 23.182920.7320.4533.36-136.79-126.55-11.52-11.313.15
Tax 6.738.206.132.5111.15-27.43-22.585.353.321.14
Profit After Tax 16.4520.8014.6017.9322.21-109.36-103.97-16.87-14.642.01
PAT Margin (%) 9.9%10.3%7.0%9.3%7.4%-34.5%-54.3%-39.6%-25.7%4.5%
Adjusted EPS (₹)8.410.67.48.710.8-53.1-50.5-8.2-7.11.0
Dividend Payout Ratio (%)15%14%20%17%14%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)

Equity and Liabilities

Shareholders Fund 105.83123.21134.37162.95181.44-2.82-125.09-148.08-162.49-158.34
Share Capital 19.6319.6319.6320.5820.5820.5820.5820.5820.5820.58
Reserves 86.21103.59114.74142.37160.87-23.39-145.66-168.66-183.07-178.91
Minority Interest0000000000
Long Term Debt4.6829.9037.2141.8079.2357.9076.4074.3273.8366.63
Short Term Debt69.1786.49111.01120.6995.49111.62146.32145.18149.48151.46
Trade Payables25.2627.1238.0735.4450.52119.2518.2120.1517.9810.24
Others Liabilities 11.7215.8221.1927.7240.057.034.345.0411.2110.33
Total Liabilities 216.67282.55341.85388.59446.73292.99120.1896.6190.0280.33

Fixed Assets

Gross Block46.6060.4664.8192.37106.2593.3595.2395.2278.5844.04
Accumulated Depreciation10.311622.0924.0728.3510.8519.0926.7925.4416.13
Net Fixed Assets36.2944.4642.7268.3077.9082.5076.1468.4353.1427.91
CWIP 30.6540.1968.52107.35112.6700000
Investments 2.1210.8613.8013.8013.910.5711.070.350.380.71
Trade Receivables38.4961.4785.1568.10102.2678.1910.308.694.6613.73
Cash Equivalents 31.4021.5718.1112.236.6310.581.460.170.400.26
Others Assets25.0540.4250.5864.1671.5750.1516.8916.0827.6036.39
Total Assets 216.67282.55341.85388.59446.73292.99120.1896.6190.0280.33

Cash Flow

(All Figures are in Crores.)
Cash Flow From Operating Activity -0.360.1224.1452.85-14.08107.3025.961.384.02-16.41
PBT 23.182920.8020.4533.36-136.79-126.55-11.52-11.313.15
Adjustment 10.319.7414.949.8613.47187.0790.5111.5614.404.61
Changes in Working Capital -27.86-32.96-4.6623.67-58.5150.2762.551.330.93-24.17
Tax Paid -5.98-5.67-6.93-1.13-2.416.75-0.56000
Cash Flow From Investing Activity -31.99-45.35-43.30-75.8716.53-119.90-64.3310.901.5117.35
Capex -34.42-23.40-32.67-66.39-19.21-60.53-54.38-0.121.5017.23
Net Investments 00000.1213.78-10.301100
Others 2.42-21.95-10.62-9.4835.62-73.150.360.020.010.11
Cash Flow From Financing Activity 22.2935.8315.3217.33-7.9115.7535.24-13.55-5.30-1.08
Net Proceeds from Shares 00010.69000000
Net Proceeds from Borrowing -3.6025.227.3111.8237.4200-10.98-0.37-0.06
Interest Paid -8.10-7.43-13.09-11.43-16.52-15.83-15.86-2.57-4.93-1.01
Dividend Paid -2.29-2.85-3.42-3.44-3.61-3.720000
Others 36.2720.8824.529.69-25.2035.3051.10000
Net Cash Flow -10.07-9.40-3.84-5.69-5.463.16-3.13-1.280.23-0.14
ROE (%)16.6118.1611.3412.0612.9N/AN/AN/AN/AN/A
ROCE (%)19.4616.9912.110.1114.14N/AN/AN/AN/AN/A
Asset Turnover Ratio0.910.860.720.570.760.930.960.390.610.53
PAT to CFO Conversion(x)-
Working Capital Days
Receivable Days6885119135979582814374
Inventory Days8598103104677070312221
Payable Days75708110069131119247157192

Omkar Speciality Chemicals Ltd Stock News

Omkar Speciality Chemicals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Omkar SpecialityChem on 18-May-2024 12:50 is ₹6.50.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 18-May-2024 12:50 the market cap of Omkar SpecialityChem stood at ₹13.36.
The latest P/E ratio of Omkar SpecialityChem as of 18-May-2024 12:50 is 0.00.
The latest P/B ratio of Omkar SpecialityChem as of 18-May-2024 12:50 is 0.00.
The 52-week high of Omkar SpecialityChem is ₹12.35 and the 52-week low is ₹5.75.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Omkar SpecialityChem is ₹19.36 ( Cr.) .

About Omkar Speciality Chemicals Ltd

Omkar Speciality Chemicals is mainly engaged in the manufacture and sale of Speciality Chemicals and Intermediates for Chemical and Allied Industries. It has four units at MIDC, Badlapur (East), District - Thane, Maharashtra. The company was originally incorporated as Omkar Speciality Chemicals on February 24, 2005 and took over business of the Proprietorship Firm Omkar Chemicals which was in operation since 1983 with Pravin S Herlekar as the Proprietor. The private limited company was converted into a public limited company on March 18, 2010.

It manufactures a range of Organic, Inorganic and Organo Inorganic Intermediates. The Inorganic Intermediates include Molybdenum derivatives, Selenium derivatives, Iodine derivatives, Cobalt derivatives, Bismuth & Tungsten derivatives and the organic intermediates include Tartaric acid derivatives and other intermediates. These products find applications in various industries like Pharmaceutical Industry, Chemical Industry, Glass Industry, Cosmetics, Ceramic Pigments and Cattle & Poultry Feeds.  The company exports its products to Europe, Canada, Asia, South America and Australia. The total exports constituted 8.69%, 12.35% and 7.97% of gross sales during FY 2008, FY 2009 and FY 2010 respectively. The chemical maker’s association with leading organizations in India and abroad has enabled it to broaden the business, to expand the existing product range and to develop new molecules as per the specific demands of its valued customers.

Omkar Speciality Chemicals has basic research capabilities and has recently acquired Rishichem Research as a wholly-owned subsidiary which is expected to provide a total R&D back-up to the company for all its future expansion and diversification programmes.

Plant and Machinery

The company’s manufacturing facilities have plant and machinery, which includes stainless steel reactors, glass lined reactors, stainless steel centrifuges, glassline centrifuges, nutsche filters, agitated filter nutsches, tray dryers, fluid bed dryers, blenders and support equipments like boilers, chilling plants, cooling tower, etc.

UnitProducts manufacturedExisting sanctioned load
Unit No.1   Iodine, Selenium,Molybdenum compounds and other derivatives73 KW (LT)
Unit No.2Iodine, Selenium,Molybdenum compounds and other derivatives377 KW (HT)
Unit No.3  Selenium Sulphide286 KW (HT)
Unit No.4  Warehouse and proposed manufacturing unit15 KW (LT)
Total751 KW

Product Portfolio

The company manufactures a range of organic, inorganic and organo inorganic intermediates. Organic intermediates are compounds rich in carbon molecules. Inorganic intermediates are compounds rich in metallic molecules. Organo inorganic intermediates are combination of carbon and metal molecules. The various products manufactured by the company in various categories are as follows:

Inorganic intermediates
Molybdenum DerivativesElectroplating, Lubricant, Water treatment chemicals
Selenium DerivativesFlucloronide, Shampoo, Pharma Intermediates, Tinted float glass, Glass industry

Iodine Derivatives

Photographic chemicals, 2- Methoxyestradiol, Nylon tyre yarn, Binfloxacin, Zaleplon, Hexestrol, Etiroxate, Idoxuridine, Rizatriptan,Adapalene, Dabelotine, Fluticasone Propionate, Pharma Intermediates, Terfenadine, Metalaxyl, Lamivudine, Alprazolam

Cobalt Derivatives

Electroplating and synthetic fibres, Ceramic pigment, Refining industry, Silica gel, Ceramic industry, Batteries, Electroplating, Cattle and Poultry feeds

Bismuth DerivativesPharma Intermediates, Auto paints, Soft Ferrites, Electronic, Cosmetics, Pharma and Anti ulcer drug
Tungsten DerivativesPharma industry
Organic intermediates
Tartaric Acid DerivativesResolving agent
Other IntermediatesDolasetron Mesylate, Terbinafine, Pioglitazone, Roziglitazone, Azoxystrobin, Seldinafen, Pharma Intermediates
Organo inorganic intermediates

Idoxifene, Benodanil, Etofenamate, Closentel, Rafoxanide, Pharma Intermediates, OPC, Electronic, Lamivudine, Orlistat, Anti DiabiticDrug, Finasteride, Rimexolone, Montelukast, Cerivastatin Sodium, Tocapone, Fluconazole, Nebirolol, Lansoprazole, Rabeprazole


  • 1983 - Formation of Omkar Chemicals with capacity of 6 MT per annum for manufacture of molybdenum derivatives
  • 2005 - The existing company takes over Omkar Chemicals. At the time of takeover, the installed capacity was 318 MT and the product range was cobalt, selenium & iodine derivatives in addition to molybdenum derivatives
  • 2006-07 - The company expands the total installed capacity to 325 MT
  • 2007-08 - The company further augments capacity to 375 MT
  • 2009 - The company sets up a new manufacturing facility at MIDC, Badlapur viz. Unit 2 with an installed capacity of 375 MT. Following setting up of this unit, its total installed capacity doubles to 750 MT.
  • Recently, Omkar Speciality Chemicals established a new manufacturing facility at B-34, MIDC, Badlapur, Thane, Maharashtra viz. Unit 3 with an installed capacity of 200 MT. With the set up of Unit 3, the company’s total installed capacity stands increased to 950 MT
  • 2010 - Omkar Speciality Chemicals becomes a public limited company
  • 2010 - The company acquires 99.82% stake in Rishichem Research and makes it wholly-owned subsidiary
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.